Westfield Capital Management CO LP Biomarin Pharmaceutical Inc Transaction History

Westfield Capital Management CO LP

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 10, 2022	SELL	$71.72 - $91.47 $46.9 Million - $59.8 Million	-654,123 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$74.77 - $85.47 $2.62 Million - $2.99 Million	35,035 Added 5.66%	654,123 $50.6 Million
Q2 2021 Aug 10, 2021	SELL	$75.51 - $84.79 $9.49 Million - $10.7 Million	-125,697 Reduced 16.88%	619,088 $51.7 Million
Q1 2021 May 14, 2021	SELL	$74.73 - $90.69 $8 Million - $9.71 Million	-107,087 Reduced 12.57%	744,785 $56.2 Million
Q4 2020 Feb 12, 2021	BUY	$72.61 - $90.2 $15.6 Million - $19.4 Million	214,792 Added 33.72%	851,872 $74.7 Million
Q3 2020 Nov 13, 2020	SELL	$71.87 - $131.03 $2.01 Million - $3.67 Million	-27,977 Reduced 4.21%	637,080 $48.5 Million
Q2 2020 Aug 13, 2020	SELL	$79.55 - $124.22 $13.8 Million - $21.6 Million	-173,600 Reduced 20.7%	665,057 $82 Million
Q1 2020 May 14, 2020	BUY	$71.37 - $96.85 $22.9 Million - $31.1 Million	321,207 Added 62.07%	838,657 $70.9 Million
Q4 2019 Feb 13, 2020	BUY	$64.27 - $86.37 $33.3 Million - $44.7 Million	517,450 New	517,450 $43.8 Million
Q1 2018 May 14, 2018	SELL	$77.67 - $92.63 $20.6 Million - $24.5 Million	-264,630 Closed	0 $0
Q4 2017 Feb 13, 2018	BUY	$80.76 - $95.13 $56,935 - $67,066	705 Added 0.27%	264,630 $23.6 Million
Q3 2017 Nov 13, 2017	BUY	$80.6 - $94.95 $21.3 Million - $25.1 Million	263,925	263,925 $24.6 Million

632

185M

1.63M

1.2M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $13.1B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Westfield Capital Management CO LP, based on Form 13F filings with the SEC.

Stay updated on Westfield Capital Management CO LP with notifications on news.